Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 9, 2005, Pages 1194-1199

  Bennett, D A ^a,b   Schneider, J A ^a,b   Wilson, R S ^a,b   Bienias, J L ^c   Berry Kravis, E ^b   Arnold, S E ^d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN CORTEX; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE REGRESSION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; AMYLOID; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; AUTOPSY; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HUMANS; MALE; REGRESSION ANALYSIS;

EID: 23944526029     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.054445     Document Type: Article

References (41)

1. Bennett DA, Schneider JA, Bienias JL, et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology in press.
2. Tang MX, Stern Y, Marder K, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998;279:751-5.
3. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer's disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol 2003;60:185-9.
4. Breitner JC, Jarvik GP, Plassman BL, et al. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years. Alzheimer Dis Assoc Disord 1998;12:40-4.
5. Sparks DL, Scheff SW, Liu H, et al. Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients. J Neurol Sci 1996;138:97-104.
6. Ghebremedhin E, Schultz C, Thai DR, Gender and age modify the association between APOE and AD-related neuropathololgy. Neurol 2001;56:1696-701.
7. Tiraboschi P, Hansen LA, Masliah E, et al. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 2004;62:1977-83.
8. Landen M, Thorsell A, Wallin A, et al. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;61:352-6.
9. Berg L, McKeel DW Jr, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998;55:326-35.
10. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 1995;333:1242-7.
11. Schmechel DE, Sounders AM, Strittmatter WJ, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-53.
12. McNamara MJ, Gomez-Isla T, Hyman BT. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease. Arch Neurol 1998;55:1001-4.
13. Gearing M, Mori H, Mirra SS. Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol 1996;39:395-9.
14. Thaker U, McDonagh AM, Iwatsubo T, et al. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease. Neuropathol Appl Neurobiol 2003;29:35-44.
15. Ohm TG, Scharnagl H, Marz W, et al. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions. Acta Neuropathol (Berl) 1999;98:273-80.
16. Mukaetova-Ladinska EB, Harrington CR, Roth M, et al. Presence of the apolipoprotein E type epsilon 4 allele is not associated with neurofibrillary pathology or biochemical changes to tau protein. Dement Geriatr Cogn Disord 1997;8:288-95.
17. MacKinnon DP, Krull JL, Lockwood CM. Equivalence of the mediation, confounding and suppression effect. Prev Sci 2000;1:173-81.
18. Victora CG, Huttly SR, Fuchs SC, et al. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol 1997;26:224-7.
19. Bennett DA, Schneider JA, Wilson RS, et al. Neurofibrillary tangles mediate the association of amyloid load and with clinical Alzheimer's disease and level of cognitive function. Arch Neurol 2004;61:378-84.
20. Schneider JA, Wilson RS, Bienias JL, et al. Cerebral infarctions and the likelihood of dementia from Alzheimer's disease pathology. Neurology 2004;62:1148-55.
21. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E ε4 allele, Alzheimer's disease pathology, and the clinical expression of Alzheimer's disease. Neurology 2003;60:246-52.
22. Bennett DA, Wilson RS, Schneider JA, et al. Education modifies the relation of AD pathology to cognitive function in older persons. Neurology 2003;60:1909-15.
23. Wilson RS, Evans DA, Bienias JL, et al. Proneness to psychological distress and risk of Alzheimer's disease. Neurology 2003;61:1579-85.
24. Bennett DA, Wilson RS, Schneider JA, et al. Cerebral infarctions and the relation of depressive symptoms to level of cognitive function in older persons. Am J Geriatric Psychiatry 2004;12:211-19.
25. Wilson RS, Schneider JA, Bienias JL, et al. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology 2003;61:1102-1108.
26. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psych Aging 2002;17:179-93.
27. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
28. Mitchell TW, Nissanov J, Man LY, et al. Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment. J Histochem Cytochem 2000;48:1627-38.
29. Bezdek JC. A convergence theorem for the fuzzy ISODATA clustering algorithm. IEEE Trans Pattern Anal Mach Intell PAMI 1980;2:1-8.
30. Mitchell TW, Mufson EJ, Schneider JA, et al. Parahippocampal tau pathology in healthy aging, mild cognitive impairment and early Alzheimer's disease. Ann Neurol 2002;51:182-9.
31. SAS Institute. SAS/STAT user's guide, version 8. Cary, NC: SAS Institute, 2000.
32. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": A practical method for grading the mental state of patients for the clinician. J Psychiatric Research 1975;12:189-98.
33. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. TINS 1994;17:525-30.
34. Pitas RE, Ji ZS, Weisgraber KH, et al. Role of apolipoprotein E in modulating neurite outgrowth: potential effect of intracellular apolipoprotein E. Biochem Soc Trans 1998;26:257-62.
35. Mahley RW, Rail SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1:507-37.
36. Wisniewski T, Castano EM, Golabek A, et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-5.
37. Permanne B, Perez C, Soto C, et al. Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants. Biochem Biophys Res Commun 1997;240:715-20.
38. Bales KR, Verina T, Cummins DJ, et al. Apolipoprotein E is essential for amyloid deposition in the APP(VZI 7F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 1999;96:15233-8.
39. Holtzman DM, Bales KR, Tenkova T, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci SA 2000;97:2892-7.
40. Holtzman DM, Fagan AM, Mackey B, et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol 2000;47:739-747.
41. Beckett LA, Bennett DA, Cochran EJ. Modeling sequential clinical observations and post-mortem data. Cleveland, OH: Biometrika Society, 1994.